Optimizing Non-Opioid Therapy for Chronic Pain
|
|
- Berenice Scott
- 5 years ago
- Views:
Transcription
1 Optimizing Non-Opioid Therapy for Chronic Pain
2 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic, electronic, or mechanical, including photocopying, recording, or information storage and retrieval systems without prior written permission of Sea Courses Inc. except where permitted by law. Sea Courses is not responsible for any speaker or participant s statements, materials, acts or omissions.
3 Learning Objectives Cite the available non-opioid medications available for managing pain Evaluate the potential risks and benefits of non-opioid medications
4 Pain Is Seen Everyday in Primary Care 1 in 5 Canadian adults suffer from chronic pain Pain is the most common reason for seeking health care Presenting complaint in up to 78% of visits to the emergency department The prevalence of pain is likely to continue to increase as our population ages The Canadian Pain Society. Pain in Canada Fact Sheet.
5 Management of Pain Is Evolving Manage pain with every option Less concern with opioids Emphasis was treating pain aggressively as the risk was thought to be minimal Increasing concerns about opioid use and addiction Need to manage pain, but large focus on safety Focus on non-opioid options
6 Each Patient With Pain Is Unique Approach to managing each case is the same: Assess Type of pain Patient characteristics Other disease states and medications Red flags What therapies can we use to treat pain?
7 Case #1: Mr. Jones Mr. Jones is here to see you to discuss his low back pain.
8 What Is the Most Important Information You Need to Determine the Treatment for Low Back Pain? a. Age of patient b. Comorbid conditions c. Current medications d. Acute or chronic e. Level of impairment f. What has been done to manage the pain g. Current imaging of his back
9 Mr. Jones: Low Back Pain 42 years old Low back pain Pain intensity 6 to 7 on 10-point scale Uses topical products for back pain Pain has flared over the last few days, and it is impacting his sleep and daily function No underlying medical conditions
10 Low Back Pain: TOP Guidelines TOP = Toward Optimized Practice Updated in December 2015 Addresses: Prevention of LBP Management of acute LBP Management of chronic LBP Patient education booklets /cpgs/885801
11 Assessment: Red Flags Alarm Feature Features of cauda equina syndrome including sudden or progressive onset of loss of bladder/bowel control, saddle anaesthesia Severe worsening pain, especially at night or when lying down Significant trauma Weight loss, history of cancer, fever Use of steroids or intravenous drugs Patient with first episode of severe back pain older than 50 years, especially older than 65 years Widespread neurological signs Referral Urgency Emergency within hours Within hours Within hours Within hours Within hours Referral within a few weeks Referral within a few weeks Toward Optimized Practice (TOP). Low Back Pain. December 2015
12 Assessment: Yellow Flags Yellow Flag Belief that pain and activity are harmful Sickness behaviours (like extended rest) Low or negative moods, social withdrawal Treatment beliefs do not fit best practice Problems with claim and compensation History of back pain, time off, other claims Problems at work, poor job satisfaction Heavy work, unsocial hours (shift work) Overprotective family or lack of support Intervention Educate and consider referral to active rehab including cognitive behavioural therapy (CBT) Educate and consider pain clinic referral Assess for psychopathology and treat Educate Connect with stakeholders and case manager Follow up regularly; refer if recovering slowly Engage case management through disability carrier Follow up regularly; refer if recovering slowly Educate patient and family Toward Optimized Practice (TOP). Low Back Pain. December 2015
13 Need to Order Images? Acute: Film imaging is indicated when compression or other fracture suspected Only order imaging to clarify anatomy where the results direct treatment Choosing Wisely: Imaging for low back pain in the first 6 weeks after pain begins should be avoided in the absence of specific clinical indications Chronic: X-rays of the lumbar spine are very poor indicators of serious pathology In the absence of clinical red flags, radiculopathy, or neurogenic claudication, spinal X-rays and MRI are of limited value Practice Tip: For most cases of low back pain, imaging is not required Toward Optimized Practice (TOP). Low Back Pain. December 2015 Choosing Wisely. American Society of Anesthesiologists Pain Medicine, 2014
14 If Our Patient Has Acute Low Back Pain If Mr. Jones is presenting with acute low back pain, which of the following non-opioid treatments is considered first line: a. Acetaminophen b. Ibuprofen c. Diclofenac d. Celecoxib e. Muscle relaxant
15 TOP Medication Recommendations for Acute Low Back Pain Medication Dose Adverse Effects Considerations First-line acetaminophen Second-line NSAIDs Add muscle relaxant if muscle spasm Up to 1,000 mg qid Negligible Primarily liver toxicity with long-term and highdose consumption Ibuprofen up to 800 mg tid Diclofenac up to 50 mg bid Cyclobenzaprine 10 mg to 30 mg per day up to 2 weeks Primarily gastrointestinal (GI), possible fluid retention, or CNS effects such as dizziness or fatigue at higher doses Sedation, dry mouth Caution over long-term use in patients > 45 years and those with cardiovascular (CV) risk factors and renal function Not robust evidence for long-term use Methocarbamol 800 1,000 mg qid prn Sedation, better tolerated than cyclobenzaprine Toward Optimized Practice (TOP). Low Back Pain. December 2015; See S, Ginzburg R. Am Fam Physician 2008;78:365
16 Acetaminophen Summary Factor Dosage Safety Liver toxicity Commentary 500 1,000 mg q4 6h prn (max 4 g / 24 h) regular, extra-strength 1,300 mg q8h (max 4 g / 24 h) timed-release arthritis formulation No dosage adjustments are required in elderly No safety concerns in patients with coronary heart disease, peptic ulcer disease, type 2 diabetes Top cause of drug-induced hepatotoxicity Vast majority of cases occur due to exceeding 4 g per day dose (1/2 intentional) Concern with unintentional is the use of multiple products with acetaminophen 5% of all patients exceed acetaminophen maximal dose Risk increases with chronic alcohol use, liver disease, dehydration, and antiepileptics Can be used in hepatic disease experts recommend dose reduction to 2 3 grams per day Imani F, et. Hepat Mon 2014;14(10); Canadian Pharmacists Association. Tylenol Product Monograph etherapeutics. Available at: Kaufman DW, et al. Pharmacoepidemiol Drug Saf 2012;21:1280
17 NSAID Summary Factor Commentary Efficacy All NSAIDs are equally effective at reducing pain and improving function 70% 80% will respond to one NSAID, so if not responding, can try other NSAID Coxib efficacy = traditional NSAID efficacy Adverse effects Can occur at therapeutic doses of NSAIDs CVD Renal GI NSAIDs and coxibs increase blood pressure by 2 5 mm Hg, decrease efficacy of angiotensin converting enzyme inhibitors (ACEIs,) angiotensin II receptor blockers (ARBs), beta-blockers, and diuretics Coxibs and diclofenac increase risk of vascular events and death (not naproxen) All NSAIDs increase the risk of hospitalization due to heart failure 1% 5% of NSAID users may develop renal adverse effects No NSAID is free of renal issues Chronic NSAID use: > 37% had significant GI lesions and 24% had ulcers 4-fold increase in upper GI tract bleeding or perforation Proton-pump inhibitors (PPIs) and coxib reduce risk but do not eliminate it Rostom A, et al. Aliment Pharmacol & Ther 2009;29:481; CNT Collaboration, et al. Lancet 2013;382:769; Harirforoosh S, et al. J Pharm Pharm Sci 2013;16:821; Cheatum DE, et al. Clinic Ther 1999;21:992
18 What About Muscle Relaxants? Meta-analysis of 30 trials for acute low back pain Muscle relaxants plus acetaminophen or NSAID were more effective than analgesic alone The combination of muscle relaxant with analgesic improves and accelerates recovery Concern is drowsiness, dizziness, and clumsiness Practice Tip: Recommended for short-term use with analgesic if muscle spasms present van Tulder MW, et al. Spine 2003:28;1978
19 Muscle Relaxant Summary Factor Dosage Adverse effects Dosing recommendations Commentary Cyclobenzaprine: 5 10 mg tid Methocarbamol: 800 1,000 mg qid Drowsiness, dry mouth, dizziness, fatigue, nausea, constipation Cyclobenzaprine is similar in structure to tricyclic antidepressants (TCAs) Short-term use Avoid in elderly Many times added at nighttime to help for sleep Use prn; discontinue if spasms are relieved Turks E, Stacey P. Low Back Pain
20 Other Recommendations for Acute Low Back Pain Keep active Slowly return to normal activity as quickly as possible Most people recover in 4 to 6 weeks with no treatment Hot and cold pads may help AVOID bed rest! Follow up if pain worsens or does not improve in 6 weeks Only consider opioids in select patients with pain not managed by first and second line Toward Optimized Practice (TOP). Low Back Pain. December 2015
21 If Our Patient Has Chronic Low Back Pain If Mr. Jones is presenting with chronic low back pain, which of the following non-opioid treatments is considered first line: a. Acetaminophen b. Ibuprofen c. Diclofenac d. Celecoxib e. Muscle relaxant
22 Administer opioids with caution TOP Medication Recommendations for Chronic Low Back Pain Medication Dose Adverse Effects Considerations Third line: TCAs Third line: codeine Fourth line: tramadol Fifth line: strong opioids Amitriptyline/Nortriptyline mg hs Codeine mg q3 4h Tramadol (slow titration); max of 400 mg/day First Line: Acetaminophen Second Line: NSAIDs Drowsiness, anticholinergic Constipation, nausea, CNS Dizziness, drowsiness, asthenia, GI, hypoglycemia Start low and go slow; can help to improve sleep Up to 30% of patients do not respond to codeine Slow titration, caution if adding to SSRI or TCA Administer with caution Morphine, hydromorphone, oxycodone, fentanyl patch Guidelines now state restricting dose to < 50 mg morphine equivalents daily SSRI = selective serotonin reuptake inhibitor Toward Optimized Practice (TOP). Low Back Pain. December 2015; Draft Recommendations & Rationales for the 2017 Canadian Opioid Guideline
23 Other Recommendations for Chronic LBP Exercise: walking and group exercise, therapeutic aquatic exercise, yoga Education: pamphlets on TOP website Self-management programs Massage therapy as adjunct Acupuncture as adjunct Cognitive behavioural therapy Respondent behavioural therapies Toward Optimized Practice (TOP). Low Back Pain. December 2015
24 When to Refer for Surgery Optimal care including combined physical and psychological treatment (6 months of care) AND Have severe LBP for which the patient would consider surgery (spinal stenosis with leg pain or claudication, LBP with leg predominant pain) Address significant psychological distress before surgery Toward Optimized Practice (TOP). Low Back Pain. December 2015
25 Summary of Low Back Pain Management Assess for red and yellow flags No need for imaging for most patients (in the absence of flags) Acetaminophen and NSAIDs are recommended first line and second line For both acute and chronic LBP Muscle relaxants can be recommended prn for spasms and to reduce discomfort Nonpharmacological recommendations are important Some patients are candidates for surgery for chronic severe pain
26 Case #2: Mrs. Chen Mrs. Chen is here to see you to discuss her fibromyalgia.
27 What Is the Most Important Information You Need to Determine the Treatment? a. Age of patient b. Comorbid conditions c. Current medications d. Mental health concerns e. Description of pain f. Location of pain g. Level of impairment h. What has been done to manage fibromyalgia
28 Mrs. Chen: Fibromyalgia 32 years old Presenting with diffuse body pain, fatigue, sleep issues, cognitive change, mood disturbance Using ibuprofen to help for pain but not experiencing significant relief Willing to try anything as she is not able to function well
29 Fibromyalgia Therapies Which of the following treatments is recommended by fibromyalgia guidelines: a. Topical NSAIDs b. Opioids c. Amitriptyline d. Ibuprofen e. All of the above
30 Fibromyalgia Guidelines 2012: : y/2016/07/04/annrheumdis full
31 Is it Fibromyalgia? Pain Predominant feature and should be present for 3 months Felt in muscle and joint tissue Neuropathic origin to pain Fatigue Up to 90% of patients and may be more disabling than pain Nonrestorative sleep impacts fatigue, affect, pain Cognitive dysfunction poor working memory, free recall, verbal fluency Mood disorder depression and anxiety in up to 75% of patients All patients with a symptom complaint suggesting a diagnosis of fibromyalgia should undergo a physical examination which should be within normal limits except for tenderness on pressure of soft tissues (ie, hyperalgesia which is increased pain response following a painful stimulus) Fitzcharles MA, et al. Pain Res Manag 2013;18:119
32 Fibromyalgia Treatment Recommendations Nonpharmacological Graduated aerobic and strengthening exercise Cognitive behavioural therapy Psychological evaluation Meditative movement therapies (qigong, yoga, tai chi) and mindfulness-based stress reduction Defined physical therapies: acupuncture or hydrotherapy Pharmacological Acetaminophen Amitriptyline (at low dose) Duloxetine Pregabalin Cyclobenzaprine With NSAIDs acting mainly in the periphery, there is little rationale for their use Direct treatment at most troublesome symptoms to improve outcomes Fitzcharles MA, et al. Pain Res Manag 2013;18:119 Macfarlane GJ, et al. Ann Rheum Dis 2017;76:318
33 Neuropathic Pain Medication Summary Commentary Medications and usual maintenance dose Adverse effects Goals of therapy Place in therapy Amitriptyline, desipramine, and nortriptyline: mg/day Gabapentin: 300 1,200 mg tid Pregabalin: mg bid Duloxetine: mg/day Vary based on the agent With fibromyalgia, important to start low and go slow As completely eliminating pain is not usually achievable, the goal for neuropathic pain is to make the pain tolerable Gabapentinoids (pregabalin, gabapentin), TCA, and serotoninnorepinephrine reuptake inhibitor (SNRI; duloxetine) are first line Moulin D, et al. Pain Res Manag 2014;19:328
34 Fibromyalgia Management Summary Important to assess symptoms besides pain Comorbid conditions and treatments can impact the management of fibromyalgia Acetaminophen is recommended first line for patients with fibromyalgia NSAIDs have limited role for patients with fibromyalgia Neuropathic pain treatment can help for pain as well as other symptoms Customize based on the patient s clinical presentation
35 Case #3: Mr. Tate Mr. Tate is here to see you to discuss his foot pain.
36 What Is the Most Important Information You Need to Determine the Treatment? a. Age of patient b. Comorbid conditions c. Current medications d. Description of pain e. Onset of foot pain f. Level of impairment g. What has been done to manage the foot pain
37 Mr. Tate: Diabetic Peripheral Neuropathy 52 years old Diabetes for 5 years Developed painful diabetic peripheral neuropathy Impairing his ability to exercise Tried acetaminophen and it is not helping for pain
38 Neuropathic Pain Guidelines Cover the pharmacological management of neuropathic pain Updated in 2014 Provide first-, second-, third-, and fourth-line recommendations Treatment is similar for diabetic peripheral neuropathy, postherpetic neuralgia, poststroke pain, multiple sclerosis pain, etc mc/articles/pmc / Moulin D, et al. Pain Res Manag 2014;19:328
39 Canadian Neuropathic Pain Guideline Recommendations Gabapentinoids TCA SNRI Tramadol Opioid Analgesic Cannabinoids Fourth-line agents (topical lidocaine, methadone, lamotrigine, tapentadol, botulinum toxin) Consider adding additional agents sequentially if partial but inadequate pain relief Moulin D, et al. Pain Res Manag 2014;19:328
40 Tailoring Treatment for Neuropathic Pain Pharmacological recommendations: First line: pregabalin/gabapentin, SNRI, TCA Tailor treatment based on patient: Avoid TCA in patients with glaucoma, orthostatic hypotension, CVD, worried about falls and weight gain Avoid duloxetine in patients with hepatic disease Avoid pregabalin and gabapentin in patients with edema and concerned about weight gain Tesfaye S, et al. Diabetes Metab Res Rev 2011;27:629
41 Diabetic Neuropathy: New 2017 ADA Position Statement Tight glycemic control Recommend duloxetine or pregabalin as initial approach Gabapentin may also be used as an effective initial approach Tricyclic antidepressants are also effective for neuropathic pain in diabetes (used with caution) Position paper has a summary of all treatments Pop-Busui R, et al. Diabetes Care 2017;40:136
42 Neuropathic Pain Summary Treatment of neuropathic pain is to address central pain sensitization Important to tailor treatment based on the patient s comorbid conditions Provide realistic treatment goals making the pain manageable versus completely eliminating the pain Important for painful diabetic neuropathy to address all aspects of patient s overall diabetes management Glycemic control Blood pressure control Dyslipidemia control
43 Key Learning Points Many different treatment options for the management of mild to moderate pain Crucial to customize based on the: Patient s medical conditions Type of pain Patient s current medications Many painful conditions can be managed with OTC analgesics By implementing guideline recommendations into practice we can optimally manage many patients in primary care without opioids
Approaches to Managing Neuropathic Pain. Nov 7, 2017
1 Approaches to Managing Neuropathic Pain Nov 7, 2017 3 Learning objectives Review the current Canadian Guidelines on Neuropathic Pain Review the diagnosis and options available for the management of Neuropathic
More informationIF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?
NON-OPIOID TREATMENT OPTIONS FOR CHRONIC PAIN Alison Knutson, PharmD, BCACP Medication Management Pharmacist Park Nicollet Creekside Clinic Dr. Knutson indicated no potential conflict of interest to this
More informationIf Not Opioids then LEAH EDMONDS CSHP OCTOBER 26, 2017
If Not Opioids then what LEAH EDMONDS CSHP OCTOBER 26, 2017 Disclosure Nothing to disclose Objectives Identify various non-opioid options for the treatment of chronic non cancer pain Choose appropriate
More informationKnock Out Opioid Abuse in New Jersey:
Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids
More informationSUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)
9 SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP) SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF ACUTE PAIN NONOPIOID TREATMENTS
More informationThis evidence-informed guideline is for non-specific, non-malignant low back pain in adults only
A Summary of the Guideline for the Evidence-Informed Primary Care Management of Low Back Pain This evidence-informed guideline is for non-specific, non-malignant low back pain in adults only Red Flags
More informationPAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More informationApproaches to Responsible Opioid Prescribing. The Opioid Naïve Patient
Approaches to Responsible Opioid Prescribing The Opioid Naïve Patient Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted
More informationPalliative Prescribing - Pain
Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing
More informationTreatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am
Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am Tim R Brown, PharmD, BCACP, FASHP Director of Clinical Pharmacotherapy Cleveland Clinic Akron General Center for Family
More informationPain Assessment & Management. For General Nursing Orientation
Pain Assessment & Management For General Nursing Orientation April 2012 Overview Definition of pain Barriers to effective pain management Types of pain Objective pain assessment Approaches to management
More informationManaging Back Pain. Faculty/Presenter Disclosure
Managing Back Pain G. Michael Allan Evidence & CPD Program, Alberta College of Family Physicians Professor, Dept Family Med, U of A. Faculty/Presenter Disclosure Faculty/Presenter: G. Michael Allan Relationships
More informationMedications for the Treatment of Neuropathic Pain
Medications for the Treatment of Neuropathic Pain February 23, 2011 Jinny Tavee, MD Associate Professor Neurological Institute Cleveland Clinic Foundation Neuropathic Pain Pain, paresthesias, and sensory
More informationGateshead Pain Guidelines for Chronic Conditions
Gateshead Pain Guidelines for Chronic Conditions Effective Date: 13.2.2013 Review Date: 13.2.2015 Gateshead Pain Guidelines: Contents PAIN GUIDELINES Chronic Non-Malignant Pain 5 Musculoskeletal Pain 6
More information21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content
Volume of Prescribing by Dentists 2011 ( a reminder) BASHD Therapeutics Analgesics and Pain Management Analgesics account for 1 in 80 dental prescriptions made A lot more analgesics will be suggested for
More informationNEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES
NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.
More informationMr. LBP: Case Presentation
CLINICAL CASES Case: Mr. LBP Mr. LBP: Case Presentation Mr. LBP is a 35-year-old male He fell down while participating in a recreational sports activity He subsequently developed low back pain Upon arrival
More informationA PATIENT GUIDE FOR MANAGING PAIN
A PATIENT GUIDE FOR MANAGING PAIN PAIN MANAGEMENT Knowing the Facts Pain can be controlled. Pain is common after surgery and with many types of illnesses. Most patients with acute and chronic pain can
More informationPain Management Management in Hepatic Hepatic and and Renal Dysfunction
Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction
More informationMitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly
Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly Mary Lynn McPherson, PharmD, MDE, MA, BCPS, CPE Professor and Executive Director, Advanced Post-Graduate
More informationDisclosures. Management of Chronic, Non- Terminal Pain. Learning Objectives. Outline. Drug Schedules. Applicable State Laws
Disclosures Management of Chronic, Non- Terminal Pain No financial disclosures or conflicts of interest to report Michael A. Smith, PharmD, BCPS Clinical Assistant Professor, University of Michigan College
More informationPharmacological treatment of Pain
Pharmacological treatment of Pain None Disclosures and Conflict of Interest Dr John F. Flannery Medical Director MSK and Multisystem Rehab Program PMR - FRCPC Objectives At the end of this presentation
More informationOrganizing your Practice for Efficient Pain Assessment. Session #4 Roman D. Jovey, MD
Organizing your Practice for Efficient Pain Assessment Session #4 Roman D. Jovey, MD 2 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More information8/6/18. Definitions. Disclosures. Technician Objectives. Pharmacist Objectives. Chronic Pain. Non-Opioid Alternatives for Chronic Pain Management
Disclosures Non-Opioid Alternatives for Chronic Management Nicholas Cox, PharmD, BCACP Clinical Pharmacist, Intensive Outpatient Clinic, University of Utah Health Pharmacist, Population Health, University
More informationDescribe Identify Compare Recognize
Goal To educate nurses about the challenges associated with treating chronic pain and the safety and efficacy of alternative therapy options in relation to Opioids. Objectives Describe the challenges associated
More information3/1/2018. Disclosures. Objectives. Clinical advisory board member- Daiichi Sankyo
Adjuvant pain medications in geriatrics Thomas B. Gregory, Pharm.D., BCPS, CPE, FASPE Clinical Pharmacy Specialist Pain Management CoxHealth Springfield, MO Disclosures Clinical advisory board member-
More informationThe NICE revised guidelines for the management of non-specific low back pain and; Implications for Practice
The NICE revised guidelines for the management of non-specific low back pain and; Implications for Practice David Walsh David.walsh@nottingham.ac.uk National Clinical Guideline Centre Commissioned by NICE
More informationPain CONCERN. Medicines for long-term pain. Antidepressants
Pain CONCERN Medicines for long-term pain Antidepressants Many people living with long-term pain (also known as chronic or persistent pain) are worried about using medicines like antidepressants. They
More informationOverview of Essentials of Pain Management. Updated 11/2016
0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.
More informationAnalgesics: Management of Pain In the Elderly Handout Package
Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed
More informationOPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN
OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN ANTOINETTE BROWN, RPH LAUREL RAMER, 2019 PHARMD CANDIDATE 2018 WYOMING CONFERENCE ON AGING LARAMIE, WY OCTOBER 3, 2018 OBJECTIVES 1. Understand the
More information9/30/2017. Case Study: Complete Pain Assessment and Multimodal Approach to Pain Management. Program Objectives. Impact of Poorly Managed Pain
Case Study: Complete Pain Assessment and Multimodal Approach to Pain Management MARY BETH PARTYKA MSN ADULT NURSE PRACTITIONER ADVOCATE CHRIST MEDICAL CENTER ADULT PAIN SERVICE Program Objectives Identify
More informationManaging Pain in the Elderly
Managing Pain in the Elderly MILES BELGRADE, MD COMPREHENSIVE PAIN CENTER MINNEAPOLIS VA The Pain Deck is Stacked Against the Elderly Osteoporosis Fractures 1 Zoster & PHN Trigeminal Neuralgia Verne 81-year-old
More informationPain Management in the
Pain Management in the Elderly Meri Hix, PharmD, CGP, BCPS Associate Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy No conflicts of interest to declare Objectives Discuss
More information외래에서흔히접하는 요통환자의진단과치료 울산의대서울아산병원가정의학과 R3 전승엽
외래에서흔히접하는 요통환자의진단과치료 울산의대서울아산병원가정의학과 R3 전승엽 Index Introduction Etiology & Type Assessment History taking & Physical examination Red flag sign Imaging Common disorder Management Reference Introduction Pain
More informationPractical Management Of Osteoporosis
Practical Management Of Osteoporosis CONFERENCE 2012 Education Centre, Bournemouth.19 November The following companies have given funding towards the cost of this meeting but have no input into the agenda
More informationCanadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain
Canadian Guideline for Opioids for Chronic Non-Cancer Pain John Fraser Community Hospital Program New Glasgow November 1, 2017 This speaker has been asked to disclose to the audience any involvement with
More informationHMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in
HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in Anesthesia and Neurology Harvard Medical School Limited time
More informationMoving On : Non-Opioid Alternatives for Chronic Pain Management
Winter Meeting February 10, 2018 Moving On : Non-Opioid Alternatives for Chronic Pain Management Nicholas Cox, PharmD, BCACP Clinical Pharmacist, Intensive Outpatient Clinic, University of Utah Health
More informationNon-opioid and adjuvant pain management
Non-opioid and adjuvant pain management ALLISON JORDAN, MD, HMDC MEDICAL DIRECTOR OF PALLIATIVE CARE SERVICES CHRISTIAN AND ALTON MEMORIAL HOSPITALS ASSOCIATE MEDICAL DIRECTOR, BJC HOSPICE ASSISTANT PROFESSOR
More informationGUIDELINES AND AUDIT IMPLEMENTATION NETWORK
GUIDELINES AND AUDIT IMPLEMENTATION NETWORK General Palliative Care Guidelines The Management of Pain at the End Of Life November 2010 Aim To provide a user friendly, evidence based guide for the management
More informationCOMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING FOR PAIN MANAGEMENT
JANUARY 2012 COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING WWW.CPSRXS. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Osteoarthritis Pain
More informationten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment
ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots
More informationNo Pain, No Gain Pharmacy Patient Pain Counseling Competition
No Pain, No Gain Pharmacy Patient Pain Counseling Competition Offered by the Maine Pharmacy Association as part of the 2010 MPA Fall Conference Sponsored by an educational grant by NASPA and Purdue Pharma,
More informationMANAGEMENT OF DIABETIC NEUROPATHY. Chungnam University Hospital Soo-Kyung, Bok, M.D., Ph.D.
MANAGEMENT OF DIABETIC NEUROPATHY Chungnam University Hospital Soo-Kyung, Bok, M.D., Ph.D. The Diabetic neuropathy cannot be reversed Not to restore function to damaged nerve Slowly progress no initial
More informationHailee Gibson, CCPA Neurosurgery Physician Assistant. Windsor Neurosurgery & Spine Associates. Windsor Regional Hospital Ouellette Campus
Hailee Gibson, CCPA Neurosurgery Physician Assistant Windsor Neurosurgery & Spine Associates Windsor Regional Hospital Ouellette Campus Disclosures I have no disclosures Learning Objectives Provide information
More informationPain Management for Adult sickle cell disease patients: Information for patients, relatives and carers
Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers Why you should read this leaflet This leaflet will give you the information necessary to manage your
More informationDiagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society Annals of Internal Medicine October 2007 Volume 147,
More informationOpioid Use and Misuse in Older Adults. Alison Moore, MD, MPH Division of Geriatrics and Gerontology
Opioid Use and Misuse in Older Adults Alison Moore, MD, MPH Division of Geriatrics and Gerontology 1 Why do older adults use opioids? Persistent pain is experienced by approximately half of people aged
More informationClinical and Contextual Evidence Reviews
Clinical and Contextual Evidence Reviews Roger Chou, MD Professor of Medicine Oregon Health & Science University Director, Pacific Northwest Evidence-based Practice Center Purpose Summarize methods for
More informationFact Sheet. Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII
Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII Fact Sheet Zohydro ER (hydrocodone bitartrate) Extended-Release Capsule, CII, is a long-acting (extendedrelease) type of pain medication
More informationDiscussion Questions WHAT ARE SOME POSSIBLE CAUSES OF HER PAIN? WHAT ELSE WOULD YOU LIKE TO KNOW
CLINICAL CASES Case: Ms. FM Case: Ms. FM Ms. FM is a 37-year-old school teacher Under your care for 10 years Unremarkable past history Was in minor car accident 4 months ago Has had progressive generalized
More informationWinter Meeting February 10, 2018
Winter Meeting February 10, 2018 Moving On : Non-Opioid Alternatives for Chronic Pain Management Nicholas Cox, PharmD, BCACP Clinical Pharmacist, Intensive Outpatient Clinic, University of Utah Health
More informationEvidence-based Clinical Practice Guidelines on Management of Pain in Older People Aza Abdulla, Margaret Bone, Nicola Adams, Alison M.
Evidence-based Clinical Practice Guidelines on Management of Pain in Older People Aza Abdulla, Margaret Bone, Nicola Adams, Alison M. Elliott, Derek Jones, Roger Knaggs, Denis Martin, Elizabeth L. Sampson,
More informationPalliative and Hospice Care of the Terminally Ill Introduction
Palliative and Hospice Care of the Terminally Ill Introduction There has been an increase in life expectancy for men and women of all races to 77.6 years Leading causes of death in older patients are chronic
More informationMid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care
Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage
More informationPharmacological and Nonpharmacological Approaches
Pharmacological and Nonpharmacological Approaches NAS Workshop December 4, 2018 Kurt Kroenke, MD, MACP Indiana University School of Medicine Regenstrief Institute, Inc. Balanced Treatment Options Medications
More informationDr. Kashyap Patel Chief Medical Officer, Agape Healthcare President, SCOS Board member, community oncology alliance Chief of Staff, Springs
Dr. Kashyap Patel Chief Medical Officer, Agape Healthcare President, SCOS 2014-15 Board member, community oncology alliance Chief of Staff, Springs Memorial Hospital CAC Member, Palmetto-GBA, Medicaid,SC
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Neuropathic pain pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist
More informationQ&A: Opioid Prescribing for Chronic Non-Malignant Pain
NHS Hastings and Rother Clinical Commissioning Group Chair Dr David Warden Chief Officer Amanda Philpott NHS Eastbourne, Hailsham and Seaford Clinical Commissioning Group Chair Dr Martin Writer Chief Officer
More informationAvera ecare Chronic Pain Management Janell Simpkins MD, FACP Avera ecare Specialty Clinic Medical Director
Chronic Pain Management Janell Simpkins MD, FACP Avera ecare Specialty Clinic Medical Director Burden of Pain 100 million Americans report ongoing pain 25 million with daily pain Pain impacts health status,
More informationDisclosures. Objectives 9/8/2015
The Aftermath of the Decade of Pain: Alternatives to Opioids in Chronic Pain Management Julie Cunningham, PharmD, BCPP Disclosures No relevant financial disclosures I will discuss off-label uses of antiepileptics,
More informationNeuropathic pain MID ESSEX LOCALITY
Neuropathic pain Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory nervous system. A. Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) i Read questions to
More informationTreatment of Anxiety (without benzos)
Treatment of Anxiety (without benzos) Alison C. Lynch MD MS Clinical Professor Departments of Psychiatry and Family Medicine University of Iowa Health Care None Disclosures Overview/objectives Review common
More informationTreating Pain and Depression
Treating Pain and Depression Without Getting Depressed Joseph P, Arpaia, MD www.jparpaiamd.com More than 50% of patients with chronic pain also have clinically significant depression. Interestingly that
More informationOPIOIDS FOR PERSISTENT PAIN: INFORMATION FOR PATIENTS
OPIOIDS FOR PERSISTENT PAIN: INFORMATION FOR PATIENTS This leaflet aims to help you understand your pain, so that you can work with your health care team to self-manage your symptoms and improve your quality
More informationINFORMATION FOR PATIENTS. Let s Manage Pain
INFORMATION FOR PATIENTS Let s Manage Pain 1 About this booklet Persistent pain, also called chronic pain, is pain which continues for longer than expected. Pain can affect all areas of your life. People
More informationTips for Pain Management
Tips for Pain Management Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy Strategies for Success in Health Management By: James J. Messina, Ph.D. What are the medical
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Referrals to Secondary Care Pain Services for Assessment and Treatment Criteria Based Access Policy Date Adopted: Version: Development Individual Funding
More informationPain Management in the Elderly. Martha Watson, MS, APRN, GCNS Christie Bowser, RN-BC, RN
Pain Management in the Elderly Martha Watson, MS, APRN, GCNS Christie Bowser, RN-BC, RN Objectives So How Much Do You Really Know? www.geriatricpain.org Geriatric Pain Knowledge Assessment The Geriatric
More informationPain Management in Older Adults. Mary Shelkey, PhD, ARNP
Pain Management in Older Adults Mary Shelkey, PhD, ARNP Cause of Death/ Demographic and Social Trends Early 1900s Current Medicine's Focus Comfort Cure Cause of Death Infectious Diseases/ Communicable
More informationCLINICAL GUIDELINES. Primary Care Guideline Summary Lumbar Spine Thomas J. Gilbert M.D., M.P.P. 3/17/15 revision
CLINICAL GUIDELINES Primary Care Guideline Summary Lumbar Spine Thomas J. Gilbert M.D., M.P.P. 3/17/15 revision TRIAGE At the initial visit, a focused history and physical examination is performed to assign
More information3/3/2015 CHRONIC PAIN MARGARET ZOELLERS, MSN, APRN
CHRONIC PAIN MARGARET ZOELLERS, MSN, APRN 1 Pain that persists or recurs > 3-6 months Pain that persists >1 month after injury/event Commonly seems out of proportion to the physical process Cause may be
More informationRecognizing Narcotic Abuse and Addiction and Helping Those With It
Recognizing Narcotic Abuse and Addiction and Helping Those With It Michael McNett, MD Medical Director for Chronic Pain Member, WI Med Society Opioid Subcommittee Ancient History 1995: OxyContin approved
More informationNeuropathic Pain Treatment Guidelines
Neuropathic Pain Treatment Guidelines Background Pain is an unpleasant sensory and emotional experience that can have a significant impact on a person s quality of life, general health, psychological health,
More informationCONCORD INTERNAL MEDICINE. Peripheral Neuropathy. April 22, 2012
CONCORD INTERNAL MEDICINE Peripheral Neuropathy Douglas G. Kelling, Jr., MD C. Gismondi-Eagan, MD, FACP George C. Monroe, III, MD April 22, 2012 The information contained in this protocol should never
More informationSteven Prakken MD Chief, Medical Pain Service Duke Pain Medicine
Steven Prakken MD Chief, Medical Pain Service Duke Pain Medicine International Association for the Study of Pain "Pain is an unpleasant sensory and emotional experience associated with actual or potential
More informationGetting at the CORE of Low-back pain Treatment Dr. John Flannery Dr. Carlo Ammendolia
Disclosure & Acknowledgment Getting at the CORE of Low-back pain Treatment Dr. John Flannery Dr. Carlo Ammendolia Disclosures - None Acknowledgements Dr. Andrea Furlan Dr. Julia Alleyne Dr. Hamilton Hall
More informationNon Malignant Pain: Symptom Management
Non Malignant Pain: Symptom Management Renal Care Symposium July 2018 Anica Vasic Pain Management Unit St George Hospital Definitions Prevalence Assessment Treatment Medications Newer agents: tapentadol,
More informationAnalgesia in patients with impaired renal function Formulary Guidance
Analgesia in patients with impaired renal function Formulary Guidance Approved by Trust D&TC: January 2010 Revised March 2017 Contents Paragraph Page 1 Aim 4 2 Introduction 4 3 Assessment of renal function
More informationDisclosures & Warnings
A truly multidisciplinary approach to managing pain and fatigue Howard P. Levy, M.D., Ph.D. Assistant Professor, Johns Hopkins University August 2, 2013 Ehlers Danlos National Foundation 2013 National
More informationBerkshire West Area Prescribing Committee Guidance
Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for
More informationTreatment with IMS: Preparation Precautions Procedures
Treatment with IMS: Preparation Precautions Procedures John Kent, BSc, MD Specialist in Family Medicine Founder, Israeli Society for Musculoskeletal Medicine Indications for IMS Myofascial component to
More informationPain and Ways to Manage It
Pain and Ways to Manage It FM.850.M311.PHC (R.Jul-15) 1 Contents This page intentionally left blank. What the words mean............................. 2 Why is it important to manage your pain?............
More informationOpioid Analgesic Treatment Worksheet
Opioid Analgesic Treatment Worksheet Aetna Better Health of Louisiana Fax: 1 844 699 2889 www.aetnabetterhealth.com/louisiana/providers/pharmacy LA Legacy Fee for Service (FFS) Medicaid Fax: 1 866 797
More informationPain is one of the most frequent clinical problems
Easing the Ouch: Relieving Short-Term Pain By Brian Goldman, MD, MCFP(EM) As presented at the Family Medicine Forum, Montreal, Quebec (November 8, 2002) Pain is one of the most frequent clinical problems
More informationNociceptive Pain. Pathophysiologic Pain. Types of Pain. At Presentation. At Presentation. Nonpharmacologic Therapy. Modulation
Learning Objectives Effective, Safe Analgesia An Approach to Appropriate Outpatient Chronic Pain Treatment By the end of this presentation, participants will be able to: Identify multiple factors that
More informationCanadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain
Canadian Guideline for Opioids for Chronic Non-Cancer Pain John Fraser Community Hospital Program North Sydney April 12, 2018 This speaker has been asked to disclose to the audience any involvement with
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationNeuropathic pain (pain due to nerve damage)
Neuropathic pain (pain due to nerve damage) Clinical Guideline Pain can be nociceptive, neuropathic or mixed. The neuropathic component of pain generally responds poorly to conventional analgesics. Consider
More informationCHAPTER 4 PAIN AND ITS MANAGEMENT
CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain
More informationThis initial discovery led to the creation of two classes of first generation antidepressants:
Antidepressants - TCAs, MAOIs, SSRIs & SNRIs First generation antidepressants TCAs and MAOIs The discovery of antidepressants could be described as a lucky accident. During the 1950s, while carrying out
More informationGuidelines for the Pharmacological Management of Chronic Pain in Primary Care. December 2012
Guidelines for the Pharmacological Management of Chronic Pain in Primary Care December 2012 NHS Portsmouth CCG Fareham and Gosport CCG South Eastern Hampshire CCG 1 Guidelines for the Pharmacological Management
More informationFibromyalgia summary. Patient leaflets from the BMJ Group. What is fibromyalgia? What are the symptoms?
Patient leaflets from the BMJ Group Fibromyalgia summary We all get aches and pains from time to time. But if you have long-term widespread pain across your whole body, you may have a condition called
More informationAgenda. Case Discussions. Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT. Daniel Alford, MD Disclosures
Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT Case Discussions August 26, 2014 PCSS MAT Webinar Sponsored by the American Psychiatric Association Daniel P. Alford, MD,
More informationThe Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders?
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD and Kellie Bunn, PA-C What are functional GI
More informationdisease or in clients who consume alcohol on a regular basis. bilirubin
NON-OPIOID Acetaminophen(Tylenol) Therapeutic class: Analgesic, antipyretic Aspirin (ASA, Acetylsalicylic Acid) Analgesic, NSAID, antipyretic Non-Opioid Analgesics COMMON USES WHAT I NEED TO KNOW AS A
More informationManaging the Chronic Pain Patient. (and some stuff about opioids)
Managing the Chronic Pain Patient. (and some stuff about opioids) C. Patrick Carroll, M.D. Assistant Professor Johns Hopkins University School of Medicine Department of Psychiatry and Behavioral Sciences
More informationOpioid Analgesic Treatment Worksheet
Opioid Analgesic Treatment Worksheet Aetna Better Health of Louisiana Fax: 1 844 699 2889 www.aetnabetterhealth.com/louisiana/providers/pharmacy LA Legacy Fee for Service (FFS) Medicaid Fax: 1 866 797
More informationRegional Renal Training
Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing
More information